Human immunodeficiency virus and type 2 diabetes

The prevalence of diabetes is higher amongst individuals infected with HIV. The major contributor to hyperglycaemia is thought to be iatrogenic, with protease inhibitors being most commonly associated to insulin resistance. This article is to update general practitioners on the diagnosis and managem...

Descripción completa

Detalles Bibliográficos
Autores principales: Avari, P., Devendra, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Case Study (Individual)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434564/
https://www.ncbi.nlm.nih.gov/pubmed/28539977
http://dx.doi.org/10.1080/17571472.2017.1302872
Descripción
Sumario:The prevalence of diabetes is higher amongst individuals infected with HIV. The major contributor to hyperglycaemia is thought to be iatrogenic, with protease inhibitors being most commonly associated to insulin resistance. This article is to update general practitioners on the diagnosis and management of diabetes in HIV-infected patients. Specific considerations are highlighted including interactions of particular diabetic drugs with antiretroviral therapy (ART). We articulate why the use of Hemoglobin A1c (HbA1c) testing is not recommended as a diagnostic tool.

Ejemplares similares